Literature DB >> 1635941

Direct access use by experienced therapists in states with direct access.

E Domholdt1, A G Durchholz.   

Abstract

Direct access use among experienced therapists practicing in states with 3 years' experience with direct access was studied, as were differences between therapists who had and had not practiced through direct access. A questionnaire was mailed to 250 members of the North Carolina, Nevada, and Utah chapters of the American Physical Therapy Association. Almost half (44.5%) of the respondents had practiced through direct access; an estimated 10.3% of their caseload was seen through direct access. Reasons for not practicing through direct access were that the employer does not permit direct access practice (49.1%), insurance does not reimburse for direct access practice (43.6%), no patients have been seen without referral (25.5%), and personal preference to treat by referral only (23.6%). Therapists who had treated patients through direct access were significantly more likely to believe that direct access had benefited them professionally and benefited their patients than were therapists who had not practiced through direct access.

Entities:  

Mesh:

Year:  1992        PMID: 1635941     DOI: 10.1093/ptj/72.8.569

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  3 in total

1.  Physical therapists in private practice: information sources and information needs.

Authors:  E F Hall
Journal:  Bull Med Libr Assoc       Date:  1995-04

2.  Diagnostic accuracy: sensitivity and specificity of the ScreenAssist Lumbar Questionnaire in comparison with primary care provider tests and measures of low back pain: a pilot study.

Authors:  Shala Cunningham
Journal:  J Man Manip Ther       Date:  2013-02

3.  Spinal pain patients seeking care in primary care and referred to physiotherapy: A cross-sectional study on patients characteristics, referral information and physiotherapy care offered by general practitioners and physiotherapists in France.

Authors:  Anthony Demont; Leila Benaïssa; Valentine Recoque; François Desmeules; Aurélie Bourmaud
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.